Analyst picks & changes

Isis Pharmaceuticals Inc.

(ISIP)

Wedbush Morgan analyst Fariba Ghodsian initiated coverage with a "buy" recommendation and a 12-month price target of $9-10.

Ghodsian said the Carlsbad, Calif., company has

Read the full 298 word article

How to gain access

Continue reading with a
two-week free trial.